Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization

Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization

Purpose: To investigate whether triptolide-nanoliposome-APRPG (TP-nanolip-APRPG), a novel sustained-release nano-drug delivery system that targets vascular endothelial cells, could enhance the inhibition of triptolide (TP) on laser-induced choroidal neovascularization (CNV). Methods: TP was encapsul...

Full description

Bibliographic Details
Main Authors: Kunbei Lai, Yingqin Li, Yajun Gong, Longhui Li, Chuangxin Huang, Fabao Xu, Xiaojing Zhong, Chenjin Jin
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Choroidal neovascularization
Triptolide
APRPG
Nanoliposome
Inflammation
Macrophage
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220309306

Internet

http://www.sciencedirect.com/science/article/pii/S0753332220309306

Similar Items